欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SK/H/0323/001
药品名称Flurbiprofen MAPAEX orange sugar free
活性成分
    • Flurbiprofen 8.75 mg
剂型Lozenge
上市许可持有人Mapaex Consumer Healthcare (Ireland) Private Limited, Ida Business Park, Green Road, Newbridge, Kildare, W12 X902, Ireland
参考成员国 - 产品名称Slovakia (SK)
互认成员国 - 产品名称
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
      Flurbiprofen MAPAEX
    • Czechia (CZ)
      Flurbiprofen Mapaex pomeranč bez cukru 8,75 mg pastilky
    • Romania (RO)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
许可日期2025/08/12
最近更新日期2025/08/12
药物ATC编码
    • R02AX01 flurbiprofen
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase